The problem we are addressing
The immune system is arguably the most complex and clinically significant system in human biology. Its state at any given moment — the balance between pro-inflammatory and anti-inflammatory activity, the distribution and activation status of lymphocyte subsets, the presence of specific immune effector cells — determines the trajectory of virtually every disease process from infection to cancer to autoimmunity.
Yet current diagnostic tools provide only fragments of this picture. A complete blood count gives cell counts. An ESR measures non-specific inflammation. A CRP provides acute-phase protein levels. Flow cytometry can characterise specific cell populations — but requires expensive equipment, trained operators, and is rarely available outside tertiary academic medical centres.
Our research approach
IMMUNOPHYSICS is exploring whether the immune state can be characterised through novel physical measurement approaches — examining the biophysical properties of immune cells and plasma components as proxies for their functional state — without requiring the staining, labelling, or biochemical reagents that make conventional immune characterisation inaccessible in low-resource settings. The program is in concept and patent development stage.
The program explores the intersection of biophysical measurement, computational immune biology, and AI pattern recognition — seeking to identify physical signal signatures that correlate with specific immune activation states, inflammatory phenotypes, and effector cell distributions.
Whether biophysical measurement signals carry sufficient information content to characterise immune state
What it's for
EtherX-1 is a frontier diagnostic platform pushing the limits of fast, reagent-free testing — advanced sensing built for the field, and for what comes next.
Intended deployment
EtherX-1 is a concept-stage platform for disciplined, high-complexity assay environments where fluidic control, clean data capture, and repeatable experimental conditions matter as much as the result itself.
A future translational research setting exploring how small biological signals may reveal immune-state change earlier than conventional workflows can detect.
A controlled laboratory setting where advanced sample handling, sealed carriers, and automated quality gates reduce operator variability before a result is interpreted.
Why it matters
At the leading edge of what a test can detect.
Engineered for answers without the wait.
Built to be trusted at the margins.
Frontier capability, made deployable.
The next chapter of the answer, written early.
Questions
It is designed to push fast, reagent-free sensing at the frontier — framed at a high level here, without revealing the underlying mechanism.
Built for field and research-forward settings, and for the wider mission of reaching communities beyond centralised healthcare.
BIQADX is at a pre-clinical, prototype stage — EtherX-1 is not currently available for commercial sale. We welcome partnership and pilot conversations.